Duncan Kennedy
Net worth: 16 485 $ as of 2024-03-30
Profile
Duncan Kennedy served as the Chief Financial Officer & Director at BTG Ltd.
from 2018 to 2019 and as the Chief Financial Officer & Executive Director at James Fisher & Sons Plc from 2021 to 2023.
Prior to these roles, he obtained an undergraduate degree from the University of Durham.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2022-12-30 | 5,000 ( 0.01% ) | 16 485 $ | 2024-03-30 |
Former positions of Duncan Kennedy
| Companies | Position | End |
|---|---|---|
| JAMES FISHER AND SONS PLC | Director of Finance/CFO | 2023-11-30 |
| BTG | Director of Finance/CFO | 2019-12-30 |
Training of Duncan Kennedy
| University of Durham | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| JAMES FISHER AND SONS PLC | Transportation |
| Private companies | 1 |
|---|---|
BTG Ltd.
 BTG Ltd. Pharmaceuticals: MajorHealth Technology BTG Ltd. is a global healthcare company, which focuses on interventional medicine that can help physicians to treat patients through minimally invasive procedures. It operates through the following segments: Product, Licensing, and Other. The firm's products include CroFab, DigiFab, Voraxage. The company was founded on December 12, 1991 and is headquartered in Farnham, the United Kingdom. | Health Technology |
- Stock Market
- Insiders
- Duncan Kennedy
